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A 24-year-old man with a six-year history of psoriasis vulgaris was referred to the dermatological outpatient clinic of the 
Complejo Hospitalario de Granada, Granada, Spain, 
in 2016 with multiple brownish cutaneous lesions of 
different sizes in the right gluteal region. No previous 
injuries, comorbid conditions or use of concomitant 
medications were reported. The patient had been 
undergoing treatment for psoriasis vulgaris with 45 mg 
of ustekinumab every three months over the previous 
eight months after other methods of treatment had 
failed, including methotrexate, cyclosporine and 
narrowband ultraviolet B phototherapy. The ustekin-
umab treatment had since resulted in good control 
of the psoriasis vulgaris (Psoriasis Area and Severity 
Index score: 0.8; body surface area: 1; Physician Global 
Assessment score: 1). However, the gluteal lesions 
had begun to appear one month after ustekinumab 
treatment was initiated.
A physical examination revealed a total of 17 
hyperpigmented nodules and plaques grouped within 
the right gluteal area ranging from 0.3–2.4 cm in size 
[Figure 1]. A polarised dermoscopy using the DermLite 
III Dermascope (3Gen LLC, San Juan Capistrano, 
California, USA) revealed a peripheral delicate 
pigment network and white scar-like patch [Figure 2]. 
A histological examination of a punch biopsy of one 
of the lesions showed acanthosis and hyperpigment-
ation of the basal keratinocytes on the epidermis with 
fibroblastic proliferation without atypia on the retic-
ular dermis [Figure 3A]. An immunohistochemical 
study indicated positivity to vimentin and factor XIIIa 
and negativity to S100 and cluster of differentiation 
(CD)34 [Figures 3B and C]. These findings excluded 
a diagnosis of dermatofibrosarcoma protuberans and 
confirmed a diagnosis of multiple dermatofibromas.
Routine laboratory investigations, including a 
complete blood count and general biochemistry, HIV, 
hepatitis B, hepatitis C, autoimmune and thyroid 
tests, were within normal limits. Serological tests 
were negative for rheumatoid factor and antinuclear 
antibodies. A purified protein derivative test and 
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Figure 1: Photograph of multiple clustered purple-brown plaques in the right gluteal region of a 24-year-old man with 
psoriasis vulgaris.
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case has been reported, the age of onset for most 
patients with multiple clustered dermatofibromas is 
between the first and third decade of life.6,7 No reports 
of metastasis or malignancy have been described so 
far, even with follow-up periods of up to 20 years.7 
In the present case, with regards to the role of 
ustekinumab, causation cannot be proven; however, 
a similar case has been described with the biological 
drug efalizumab.8 Moreover, the development of 
multiple eruptive dermatofibromas in immuno-
modulated situations could be explained by the 
inhibition of downregulatory T cells.8–10 Systemic lupus 
erythematosus is the most common underlying disease 
associated with multiple eruptive dermatofibromas.9 
However, it is important to note that the degree of 
immunosuppression does not seem to correlate with 
the number of dermatofibromas.11
Histologically, the differential diagnosis for 
multiple clustered dermatofibromas includes derma-
tofibrosarcomas protuberans, dermatomyofibromas, 
leiomyomas and, in paediatric cases, plaque-like myo-
fibroblastic tumours. Immunostaining with CD34 
may be helpful in confirming the diagnosis.12 Clinically, 
the lesions may mimic atypical fibroxanthomas, 
nodular fasciitis and dermatofibrosis lenticularis 
disseminata.13 From a therapeutic point of view, a 
conservative approach is advisable. Techniques used 
with varying success include cryotherapy, intra-
lesional steroids, surgery and phototherapy.13,14
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radiography of the thorax also indicated no anomalies. 
With the patient’s consent, the decision was made 
to continue ustekinumab treatment. As the patient 
refused any surgical or medical treatment, the lesions 
persisted.
Comment
Multiple dermatofibromas are defined as the appear-
ance of at least 15 dermatofibromas in less than a year 
or 5–8 dermatofibromas within four months.1 Dupré 
et al. first used the term ‘clustered’ in 1984 to refer to 
the grouping of these lesions in a segmental 
distribution.2 To date, very few cases of multiple 
clustered dermatofibromas have been reported in 
the literature.3 The individual lesions of multiple 
dermatofibromas are not clinically, histologically or 
phenotypically different from that of a solitary 
dermatofibroma.3 
Multiple clustered dermatofibromas have not 
been found to be associated with any underlying 
malignancies, immunosupression, previous trauma 
or other comorbidities.4 Viseux et al. reported a 
kidney transplant patient who had developed multiple 
clustered dermatofibromas over the pathway of 
thrombosed superficial veins.5 Although a congenital 
 
Figure 2: Dermoscopy image at x10 magnification showing a 
peripheral delicate pigment network (arrow) and white scar-
like patch (asterisk).
 
Figure 3: A: Haematoxylin and eosin stain of a punch biopsy at x2 magnification showing a proliferation of spindle 
cells (arrow) in the dermis and subcutaneous tissue. B: Immunohistochemistry stain at x4 magnification showing cells 
negative for cluster of differentiation (CD)34 (arrow). C: Immunohistochemistry stain at x10 magnification showing cells 
positive for factor XIII (arrow).
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